Review



ebv peptide mix  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Miltenyi Biotec ebv peptide mix
    CD8 + T-cell polyfunctionality analysis after ex vivo expansion with specific SARS CoV-2 peptides derived from the SARS-CoV-2 NC. (a and c) Representative dot plots showing effector cytokine production and degranulation level of CD8 + T cells stimulated with RTATKAYNV (a) and IIWVATEGA (c) peptides. The CD8 + T cells were derived from two HLA-A*02-positive SARS-CoV-2 convalescent <t>donors.</t> <t>PBMCs</t> from an HLA-A*02-negative SARS-CoV-2 convalescent donor were used as a negative control. The clinical samples were obtained at 1 to 2 months after SARS-CoV-2 recovery. (b and d) Bar charts represent the effector profiles of RTATKAYNV (b)- and IIWVATEGA (d)-specific CD8 + T cells. PBMCs expanded with <t>EBV</t> peptides were used as positive control. Pies depict the distribution of mono-, bi-, tri-, and tetrafunctional cells within specific CD8 + T cells.
    Ebv Peptide Mix, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ebv+mix+peptides/MACS+GMP+PepTivator+EBV+Select/pmc08579755-306-64-84
    Average 93 stars, based on 4 article reviews
    ebv peptide mix - by Bioz Stars, 2026-09
    93/100 stars

    Images

    1) Product Images from "Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity"

    Article Title: Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity

    Journal: Journal of Virology

    doi: 10.1128/JVI.02002-20

    CD8 + T-cell polyfunctionality analysis after ex vivo expansion with specific SARS CoV-2 peptides derived from the SARS-CoV-2 NC. (a and c) Representative dot plots showing effector cytokine production and degranulation level of CD8 + T cells stimulated with RTATKAYNV (a) and IIWVATEGA (c) peptides. The CD8 + T cells were derived from two HLA-A*02-positive SARS-CoV-2 convalescent donors. PBMCs from an HLA-A*02-negative SARS-CoV-2 convalescent donor were used as a negative control. The clinical samples were obtained at 1 to 2 months after SARS-CoV-2 recovery. (b and d) Bar charts represent the effector profiles of RTATKAYNV (b)- and IIWVATEGA (d)-specific CD8 + T cells. PBMCs expanded with EBV peptides were used as positive control. Pies depict the distribution of mono-, bi-, tri-, and tetrafunctional cells within specific CD8 + T cells.
    Figure Legend Snippet: CD8 + T-cell polyfunctionality analysis after ex vivo expansion with specific SARS CoV-2 peptides derived from the SARS-CoV-2 NC. (a and c) Representative dot plots showing effector cytokine production and degranulation level of CD8 + T cells stimulated with RTATKAYNV (a) and IIWVATEGA (c) peptides. The CD8 + T cells were derived from two HLA-A*02-positive SARS-CoV-2 convalescent donors. PBMCs from an HLA-A*02-negative SARS-CoV-2 convalescent donor were used as a negative control. The clinical samples were obtained at 1 to 2 months after SARS-CoV-2 recovery. (b and d) Bar charts represent the effector profiles of RTATKAYNV (b)- and IIWVATEGA (d)-specific CD8 + T cells. PBMCs expanded with EBV peptides were used as positive control. Pies depict the distribution of mono-, bi-, tri-, and tetrafunctional cells within specific CD8 + T cells.

    Techniques Used: Ex Vivo, Derivative Assay, Negative Control, Positive Control

    Related Articles

    other:

    Article Title: The efficacy and safety of Epstein-Barr virus-specific antigen peptide-activated cytotoxic T-cells treatment for refractory or recurrent angioimmunoblastic T-cell lymphoma: A prospective clinical observational study.
    Article Snippet: The efficacy and safety of Epstein-Barr virus (EBV) specific antigen peptide-activated cytotoxic T cells (CTLs) in the treatment of refractory or recurrent angioimmunoblastic T cell lymphoma(AITL)was determined in this prospective one-arm clinical study.. 7 males and 2 females were enrolled with a median age of 70 years.. The tumor stages were all stage III-IV.



    Similar Products

    ebv peptide mix  (Miltenyi Biotec)
    93
    Miltenyi Biotec ebv peptide mix
    CD8 + T-cell polyfunctionality analysis after ex vivo expansion with specific SARS CoV-2 peptides derived from the SARS-CoV-2 NC. (a and c) Representative dot plots showing effector cytokine production and degranulation level of CD8 + T cells stimulated with RTATKAYNV (a) and IIWVATEGA (c) peptides. The CD8 + T cells were derived from two HLA-A*02-positive SARS-CoV-2 convalescent <t>donors.</t> <t>PBMCs</t> from an HLA-A*02-negative SARS-CoV-2 convalescent donor were used as a negative control. The clinical samples were obtained at 1 to 2 months after SARS-CoV-2 recovery. (b and d) Bar charts represent the effector profiles of RTATKAYNV (b)- and IIWVATEGA (d)-specific CD8 + T cells. PBMCs expanded with <t>EBV</t> peptides were used as positive control. Pies depict the distribution of mono-, bi-, tri-, and tetrafunctional cells within specific CD8 + T cells.
    Ebv Peptide Mix, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ebv+mix+peptides/MACS+GMP+PepTivator+EBV+Select/pmc08579755-306-64-84
    Average 93 stars, based on 1 article reviews
    ebv peptide mix - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    ebv peptide mix  (Proimmune)
    90
    Proimmune ebv peptide mix
    Biological parameters in the 49 SOT patients after stratification by tumor occurrence.
    Ebv Peptide Mix, supplied by Proimmune, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ebv+mix+peptides/ebv+peptide+mix/pmc08567137-171-2-6
    Average 90 stars, based on 1 article reviews
    ebv peptide mix - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    epstein barr virus ebv peptide mix  (Miltenyi Biotec)
    93
    Miltenyi Biotec epstein barr virus ebv peptide mix
    Biological parameters in the 49 SOT patients after stratification by tumor occurrence.
    Epstein Barr Virus Ebv Peptide Mix, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ebv+mix+peptides/MACS+GMP+PepTivator+EBV+Select/pmc08579755-306-23-33
    Average 93 stars, based on 1 article reviews
    epstein barr virus ebv peptide mix - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    ebv mix peptides  (Miltenyi Biotec)
    90
    Miltenyi Biotec ebv mix peptides
    Biological parameters in the 49 SOT patients after stratification by tumor occurrence.
    Ebv Mix Peptides, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ebv+mix+peptides/ebv+mix+peptide/pm32083758-59-7-10
    Average 90 stars, based on 1 article reviews
    ebv mix peptides - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    latent and lytic ebv-specific peptide mix  (GenID GmbH)
    90
    GenID GmbH latent and lytic ebv-specific peptide mix
    Biological parameters in the 49 SOT patients after stratification by tumor occurrence.
    Latent And Lytic Ebv Specific Peptide Mix, supplied by GenID GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ebv+mix+peptides/latent+and+lytic+ebv+specific+peptide+mix/pm31289930-44-6-11
    Average 90 stars, based on 1 article reviews
    latent and lytic ebv-specific peptide mix - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    peptide mix containing 15-mer peptides spanning ebv-lmp2 protein  (Jerini Inc)
    90
    Jerini Inc peptide mix containing 15-mer peptides spanning ebv-lmp2 protein
    Biological parameters in the 49 SOT patients after stratification by tumor occurrence.
    Peptide Mix Containing 15 Mer Peptides Spanning Ebv Lmp2 Protein, supplied by Jerini Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ebv+mix+peptides/lmp2+pepmix/pm21586688-42-45-47
    Average 90 stars, based on 1 article reviews
    peptide mix containing 15-mer peptides spanning ebv-lmp2 protein - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    peptide mix containing 15-mer peptides spanning the ebv lmp-2 protein  (Jerini Inc)
    90
    Jerini Inc peptide mix containing 15-mer peptides spanning the ebv lmp-2 protein
    Biological parameters in the 49 SOT patients after stratification by tumor occurrence.
    Peptide Mix Containing 15 Mer Peptides Spanning The Ebv Lmp 2 Protein, supplied by Jerini Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ebv+mix+peptides/peptide+mix+containing+15+mer+peptides+spanning+the+ebv+lmp+2+protein/pm16796723-55-27-34
    Average 90 stars, based on 1 article reviews
    peptide mix containing 15-mer peptides spanning the ebv lmp-2 protein - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    peptide mix containing 15-mer peptides spanning the ebv lmp2 protein  (Jerini Inc)
    90
    Jerini Inc peptide mix containing 15-mer peptides spanning the ebv lmp2 protein
    Biological parameters in the 49 SOT patients after stratification by tumor occurrence.
    Peptide Mix Containing 15 Mer Peptides Spanning The Ebv Lmp2 Protein, supplied by Jerini Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ebv+mix+peptides/lmp2+pepmix/10__1200_slash_jco__2005__02__6195-54-59-69
    Average 90 stars, based on 1 article reviews
    peptide mix containing 15-mer peptides spanning the ebv lmp2 protein - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    CD8 + T-cell polyfunctionality analysis after ex vivo expansion with specific SARS CoV-2 peptides derived from the SARS-CoV-2 NC. (a and c) Representative dot plots showing effector cytokine production and degranulation level of CD8 + T cells stimulated with RTATKAYNV (a) and IIWVATEGA (c) peptides. The CD8 + T cells were derived from two HLA-A*02-positive SARS-CoV-2 convalescent donors. PBMCs from an HLA-A*02-negative SARS-CoV-2 convalescent donor were used as a negative control. The clinical samples were obtained at 1 to 2 months after SARS-CoV-2 recovery. (b and d) Bar charts represent the effector profiles of RTATKAYNV (b)- and IIWVATEGA (d)-specific CD8 + T cells. PBMCs expanded with EBV peptides were used as positive control. Pies depict the distribution of mono-, bi-, tri-, and tetrafunctional cells within specific CD8 + T cells.

    Journal: Journal of Virology

    Article Title: Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity

    doi: 10.1128/JVI.02002-20

    Figure Lengend Snippet: CD8 + T-cell polyfunctionality analysis after ex vivo expansion with specific SARS CoV-2 peptides derived from the SARS-CoV-2 NC. (a and c) Representative dot plots showing effector cytokine production and degranulation level of CD8 + T cells stimulated with RTATKAYNV (a) and IIWVATEGA (c) peptides. The CD8 + T cells were derived from two HLA-A*02-positive SARS-CoV-2 convalescent donors. PBMCs from an HLA-A*02-negative SARS-CoV-2 convalescent donor were used as a negative control. The clinical samples were obtained at 1 to 2 months after SARS-CoV-2 recovery. (b and d) Bar charts represent the effector profiles of RTATKAYNV (b)- and IIWVATEGA (d)-specific CD8 + T cells. PBMCs expanded with EBV peptides were used as positive control. Pies depict the distribution of mono-, bi-, tri-, and tetrafunctional cells within specific CD8 + T cells.

    Article Snippet: The rested PBMCs ([3 to 5] × 10 6 cells) were incubated in the presence of 5 μM of SARS-CoV-2 peptide pools or Epstein-Barr Virus (EBV) peptide mix (MACS GMP PepTivator EBV select, Miltenyi Biotec) for 1 h. Two SARS-CoV-2 peptides derived from the NC ( RTATKAYNV and IIWVATEGA ; 5 μM for each peptide) were used to stimulate PBMCs for 1 h. The EBV peptide mix (resuspended at 100 μg/ml in DMSO) was used for a positive control (MACS GMP PepTivator EBV Select; Miltenyi Biotec).

    Techniques: Ex Vivo, Derivative Assay, Negative Control, Positive Control

    Biological parameters in the 49 SOT patients after stratification by tumor occurrence.

    Journal: Frontiers in Oncology

    Article Title: Biological Predictors of De Novo Tumors in Solid Organ Transplanted Patients During Oncological Surveillance: Potential Role of Circulating TERT mRNA

    doi: 10.3389/fonc.2021.772348

    Figure Lengend Snippet: Biological parameters in the 49 SOT patients after stratification by tumor occurrence.

    Article Snippet: CMV, EBV, Survivin, TERT peptide mixes (ProImmune, Oxford UK; 0.2ng/mL of each peptide mix) or unspecific stimuli (0.5mg/mL αCD3/αCD28) were resuspended in CTL-test Medium, plated in triplicate and incubated for 10-20 minutes.

    Techniques:

    Cox regression analysis evaluating the associations between baseline demographic, clinical or biological parameters and tumor onset.

    Journal: Frontiers in Oncology

    Article Title: Biological Predictors of De Novo Tumors in Solid Organ Transplanted Patients During Oncological Surveillance: Potential Role of Circulating TERT mRNA

    doi: 10.3389/fonc.2021.772348

    Figure Lengend Snippet: Cox regression analysis evaluating the associations between baseline demographic, clinical or biological parameters and tumor onset.

    Article Snippet: CMV, EBV, Survivin, TERT peptide mixes (ProImmune, Oxford UK; 0.2ng/mL of each peptide mix) or unspecific stimuli (0.5mg/mL αCD3/αCD28) were resuspended in CTL-test Medium, plated in triplicate and incubated for 10-20 minutes.

    Techniques: